We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
-1.09%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.68B
AUM Growth
-$375M
Cap. Flow
-$261M
Cap. Flow %
-7.11%
Top 10 Hldgs %
10.92%
Holding
331
New
26
Increased
99
Reduced
137
Closed
37

Top Buys

Rank Stock Value
1
OMCL icon
Omnicell
OMCL
+$19.6M
2
ATKR icon
Atkore
ATKR
+$18.3M
3
VRRM icon
Verra Mobility
VRRM
+$18.1M
4
PLMR icon
Palomar
PLMR
+$14.1M
5
BLUE
bluebird bio
BLUE
+$13.8M

Top Sells

Rank Stock Value
1
GWR
Genesee & Wyoming Inc.
GWR
+$31.1M
2
CPRT icon
Copart
CPRT
+$29.6M
3
ARRY
Array Biopharma Inc
ARRY
+$25.2M
4
NEWR
New Relic, Inc.
NEWR
+$18.7M
5
CBLK
Carbon Black, Inc. Common Stock
CBLK
+$16.8M

Sector Composition

Rank Sector Weight
1 Technology 22.75%
2 Healthcare 18.85%
3 Financials 15.11%
4 Industrials 13.13%
5 Consumer Discretionary 12.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GIII icon
101
G-III Apparel Group
GIII
$1.48B
$15.8M 0.43%
614,074
+20,173
+3% +$506K
EBS icon
102
Emergent Biosolutions
EBS
$229M
$15.8M 0.43%
301,487
-22,398
-7% -$1.04M
HQY icon
103
HealthEquity
HQY
$8.93B
$15.7M 0.43%
275,076
-212,769
-44% -$14.1M
STLD icon
104
Steel Dynamics
STLD
$38.5B
$15.5M 0.42%
520,311
+17,346
+3% +$512K
DOOR
105
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$15.4M 0.42%
265,990
+8,744
+3% +$464K
BKNG icon
106
Booking.com
BKNG
$160B
$15.4M 0.42%
196,375
+625
+0.3% +$48.4K
ALNY icon
107
Alnylam Pharmaceuticals
ALNY
$29B
$15.4M 0.42%
191,285
-39,757
-17% -$3.15M
MIME
108
DELISTED
Mimecast Limited
MIME
$15.2M 0.41%
427,067
+51,431
+14% +$2.24M
MDRX
109
DELISTED
Veradigm Inc. Common Stock
MDRX
$15.2M 0.41%
1,386,397
+45,865
+3% +$471K
ONTO icon
110
Onto Innovation
ONTO
$14.5B
$15.2M 0.41%
465,991
+15,663
+3% +$488K
VRTS icon
111
Virtus Investment Partners
VRTS
$1.11B
$15.1M 0.41%
136,523
-28,527
-17% -$3.07M
ALXN
112
DELISTED
Alexion Pharmaceuticals
ALXN
$14.9M 0.41%
152,027
-13,859
-8% -$1.56M
MTZ icon
113
MasTec
MTZ
$21.5B
$14.6M 0.4%
225,299
-52,055
-19% -$3.04M
ZUO
114
DELISTED
Zuora, Inc.
ZUO
$14.6M 0.4%
972,007
+31,840
+3% +$479K
WNC icon
115
Wabash National
WNC
$510M
$14.5M 0.39%
1,000,499
+33,261
+3% +$492K
LGF.B
116
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$14.4M 0.39%
1,652,936
-106,078
-6% -$1.14M
TFIN icon
117
Triumph Financial Inc
TFIN
$1.8B
$14.2M 0.39%
445,789
+14,696
+3% +$443K
ACAD icon
118
Acadia Pharmaceuticals
ACAD
$5.06B
$14.2M 0.39%
394,253
-144,025
-27% -$4.37M
WMGI
119
DELISTED
Wright Medical Group Inc
WMGI
$13.5M 0.37%
655,413
-185,945
-22% -$4.43M
CDNA icon
120
CareDx
CDNA
$2.44B
$13.5M 0.37%
596,339
+154,167
+35% +$4.27M
NVTA
121
DELISTED
Invitae Corporation
NVTA
$13.4M 0.36%
694,713
-7,645
-1% -$180K
SIMO icon
122
Silicon Motion
SIMO
$7.82B
$13.3M 0.36%
375,342
+12,079
+3% +$438K
GLOG
123
DELISTED
GASLOG LTD
GLOG
$13M 0.35%
1,008,978
+33,846
+3% +$453K
PCRX icon
124
Pacira BioSciences
PCRX
$974M
$12.9M 0.35%
338,964
+40,203
+13% +$1.6M
PTLA
125
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$12.8M 0.35%
476,863
+12,398
+3% +$348K
3 4
5
6 7

Similar funds

CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
EP
Edgestream Partners Princeton, New Jersey $3.05B AUM 12.73% 1-Year Est. Return

Peregrine Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Peregrine Capital Management held 331 positions worth $3.68B, down 9.3% from $4.05B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Peregrine Capital Management withdrew a net $261M in Q3 2019, closing 37 positions and reducing 137 holdings. Its most notable exit was Genesee & Wyoming Inc., an estimated $31.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Peregrine Capital Management opened a new position in Atkore worth $19.8M.

  • Peregrine Capital Management's largest Q3 2019 buy was Atkore: 651,484 shares worth $19.8M.
  • Peregrine Capital Management added most to Omnicell in Q3 2019, an estimated $19.6M increase.
  • Peregrine Capital Management's biggest Q3 2019 reduction was Copart, cutting an estimated $29.6M.
  • Peregrine Capital Management fully exited Genesee & Wyoming Inc. in Q3 2019, selling an estimated $31.1M.
  • Peregrine Capital Management's ten largest holdings make up 11% of its $3.68B portfolio in Q3 2019.
  • Peregrine Capital Management opened 26 new positions and closed 37 in Q3 2019.
  • Peregrine Capital Management's portfolio value fell 9.3% quarter-over-quarter to $3.68B.

Based on Peregrine Capital Management's 13F filing for Q3 2019, filed 16 Oct 2019.